Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 52Ovarian Neoplasms 40Multiple Myeloma 20Fallopian Tube Neoplasms 13Lymphoma 12Sarcoma 11Carcinoma, Ovarian Epithelial 11Triple Negative Breast Neoplasms 8Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Lymphoma, Non-Hodgkin 7Hodgkin Disease 6Neoplasms, Plasma Cell 5Sarcoma, Ewing 4Prostatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Mantle-Cell 4Burkitt Lymphoma 4Rhabdomyosarcoma 3Osteosarcoma 3Lymphoma, T-Cell, Peripheral 3Leiomyosarcoma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2

Interventions

Imatinib Mesylate 3Cryosurgery 3nirogacestat 2Blood Specimen Collection 2vactosertib 1strattice 1liposomal doxorubicin 1Toremifene 1Taxes 1Surveys and Questionnaires 1Sunitinib 1Sirolimus 1Saline Solution 1Radiofrequency Ablation 1Pregnancy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Hydroxyurea 1High-Intensity Focused Ultrasound Ablation 1Embolization, Therapeutic 1Electrochemotherapy 1Doxorubicin 1Data Collection 1Cyclophosphamide 1Cryotherapy 1Bleomycin 1Biopsy 1Albumin-Bound Paclitaxel 1Abdominoplasty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Desmoid Tumors × liposomal doxorubicin × Clear all
NCT02557854 2019-03-19

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

University of Texas Southwestern Medical Center

Phase 1 Withdrawn
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡